Drug Type Small molecule drug |
Synonyms Sodium polystyrene sulfonate (JP17/USP), Kalexate + [4] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (05 Jun 1958), |
Regulation- |
Molecular FormulaC8H8NaO3S |
InChIKeyOMSKWMHSUQZBRS-UHFFFAOYSA-N |
CAS Registry25704-18-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03263 | Sodium Polystyrene Sulfonate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperkalemia | JP | 14 Sep 1970 |
Not Applicable | - | - | Sodium Polystyrene Sulfonate (SPS) | pfmzvqmmle(efdxexrqtb) = jbstaoegsm iifipqekrz (oiveqjflqv ) View more | Negative | 27 Oct 2021 | |
pfmzvqmmle(efdxexrqtb) = aplwukfmkx iifipqekrz (oiveqjflqv ) View more | |||||||
Not Applicable | Hyperkalemia Maintenance | - | ewffcixwfr(rtlgsrvijd) = trawtkayhg uyxehmqpii (qinwpbqnzm ) View more | Positive | 23 Oct 2018 | ||
ewffcixwfr(rtlgsrvijd) = kgqdfygvwq uyxehmqpii (qinwpbqnzm ) View more | |||||||
Not Applicable | - | eynjlmuwbl(mbfzjrsxwt) = jnamwjudkl rawmlmgrpr (lzddjbipps ) | Negative | 03 Nov 2015 | |||
Phase 4 | 32 | (Sodium Polystyrene Sulfonate) | wmlzrbjhmj(yhfofewoio) = giqtkikuqj ixzlrahvgh (tvftfghbhb, ltsofzunzq - kkiififoeu) View more | - | 03 Sep 2014 | ||
Silicified microcrystalline cellulose (Silicified Microcrystalline Cellulose) | wmlzrbjhmj(yhfofewoio) = xmndmyhbwi ixzlrahvgh (tvftfghbhb, lrqzbkdcup - abwlxwtail) View more |